GraceFinance · Source-backed public company research
Emergent BioSolutions Inc. (EBS)
NYSE · Manufacturing · Pharmaceutical Preparations
Core research established · 4/4 core data layers currently established
What Emergent BioSolutions Inc. does
OVERVIEW We are a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate and naturally occurring Public Health Threats (“PHTs”). Our solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing (“CDMO”) services portfolio. The types of PHTs we are currently addressing are focused on the following four categories: •chemical, biological, radiological, nuclear and explosives (“CBRNE”); •emerging infectious diseases (“EID”); •emerging health crises; and •acute, emergency and community care.
Open the company story
The live GraceFinance page shows source-backed financial changes, management context, guidance, confirmed events, risks, and connected history only when the applicable evidence and relationships have been established. Missing research stays visible instead of being inferred.